Redefining quality - Implications of recent clinical trials

被引：55

作者：

Krumholz, Harlan M. ^{[1
,2
]}

Lee, Thomas H. ^{[3
]}

机构：

[1] Yale Univ, Sch Med, New Haven, CT 06504 USA

[2] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA

[3] Partners Healthcare Syst, Boston, MA USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 24期

关键词：

D O I：

10.1056/NEJMp0803740

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2537 / 2539

页数：3

共 7 条

[1] Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].

Anderson, GL ;

Limacher, M ;

Assaf, AR ;

Bassford, T ;

Beresford, SAA ;

Black, H ;

Bonds, D ;

Brunner, R ;

Brzyski, R ;

Caan, B ;

Chlebowski, R ;

Curb, D ;

Gass, M ;

Hays, J ;

Heiss, G ;

Hendrix, S ;

Howard, BV ;

Hsia, J ;

Hubbell, A ;

Jackson, R ;

Johnson, KC ;

Judd, H ;

Kotchen, JM ;

Kuller, L ;

LaCroix, AZ ;

Lane, D ;

Langer, RD ;

Lasser, N ;

Lewis, CE ;

Manson, J ;

Margolis, K ;

Ockene, J ;

O'Sullivan, MJ ;

Phillips, L ;

Prentice, RL ;

Ritenbaugh, C ;

Robbins, J ;

Rossouw, JE ;

Sarto, G ;

Stefanick, ML ;

Van Horn, L ;

Wactawski-Wende, J ;

Wallace, R ;

Wassertheil-Smoller, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712

[2]

Gillespie MJ, 2006, CIRCULATION, V113, pE805

[3]

Nissen SE, 2007, NEW ENGL J MED, V357, P100

[4] Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes (vol 356, pg 2457, 2007) [J].

Nissen, Steven E. ;

Wolski, Kathy .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) :2457-2471

[5] Effect of torcetrapib on the progression of coronary atherosclerosis [J].

Nissen, Steven E. ;

Tardif, Jean-Claude ;

Nicholls, Stephen J. ;

Revkin, James H. ;

Shear, Charles L. ;

Duggan, William T. ;

Ruzyllo, Witold ;

Bachinsky, William B. ;

Lasala, Gregory P. ;

Tuzcu, E. Murat .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (13) :1304-1316

[6] AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - Endorsed by the National Heart, Lung, and Blood Institute [J].

Smith, Sidney C., Jr. ;

Allen, Jerilyn ;

Blair, Steven N. ;

Bonow, Robert O. ;

Brass, Lawrence M. ;

Fonarow, Gregg C. ;

Grundy, Scott M. ;

Hiratzka, Loren ;

Jones, Daniel ;

Krumholz, Harlan M. ;

Mosca, Lori ;

Pasternak, Richard C. ;

Pearson, Thomas ;

Pfeffer, Marc A. ;

Taubert, Kathryn A. .

CIRCULATION, 2006, 113 (19) :2363-2372

[7] Telmisartan, ramipril, or both in patients at high risk for vascular events [J].

Yusuf, Salim ;

Teo, Koon K. ;

Pogue, Janice ;

Dyal, Leanne ;

Copland, Ingrid ;

Schumacher, Helmut ;

Ingelheim, Boehringer ;

Dagenais, Gilles ;

Sleight, Peter ;

Anderson, Craig .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (15) :1547-1559

← 1 →